New “Quad” Pills Safe and Effective

A new study has shown that the ‘Quad’ single-tablet regimen has antiviral efficacy at least as good as comparison regimens and is associated with fewer adverse events than Atripla or ritonavir-boosted atazanavir (Reyataz). The new four-in-one ‘Quad’ coformulation contains the next-generation integrase inhibitor elvitegravir, the novel boosting agent cobicistat, and tenofovir and FTC (the latter two are […]

New Once-a-Day Drugs Get Approval

In recent years, HIV drugs have been combined, to make them easier to take by reducing the number of pills that need to be swallowed. Perhaps the most well-know example of this is Atripla, a one pill, once-a-day HIV treatment containing efavirenz, emtricitabine, and tenofovir. Efavirenz is a type of medicine called a non-nucleoside reverse transcriptase […]